Share on StockTwits

EnteroMedics (NASDAQ:ETRM) saw a significant increase in short interest in June. As of June 13th, there was short interest totalling 7,699,305 shares, an increase of 35.9% from the May 30th total of 5,665,335 shares, Stock Ratings News reports. Based on an average trading volume of 2,681,013 shares, the short-interest ratio is currently 2.9 days. Approximately 15.1% of the shares of the stock are short sold.

ETRM has been the subject of a number of recent research reports. Analysts at Roth Capital raised their price target on shares of EnteroMedics from $3.00 to $5.00 in a research note on Wednesday, June 18th. They now have a “buy” rating on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of EnteroMedics to $5.00 in a research note on Monday, June 16th. They now have a “buy” rating on the stock. Finally, analysts at Canaccord Genuity cut their price target on shares of EnteroMedics from $6.00 to $4.00 in a research note on Thursday, May 1st. Five equities research analysts have rated the stock with a buy rating, EnteroMedics presently has an average rating of “Buy” and a consensus target price of $5.20.

EnteroMedics (NASDAQ:ETRM) opened at 1.63 on Monday. EnteroMedics has a 1-year low of $1.00 and a 1-year high of $2.66. The stock’s 50-day moving average is $1.80 and its 200-day moving average is $2.0. The company’s market cap is $109.5 million.

EnteroMedics (NASDAQ:ETRM) last issued its quarterly earnings data on Wednesday, April 30th. The company reported ($0.10) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.10). During the same quarter in the prior year, the company posted ($0.14) earnings per share. On average, analysts predict that EnteroMedics will post $-0.38 earnings per share for the current fiscal year.

EnteroMedics Inc (NASDAQ:ETRM) is a development- stage medical device company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.